PubMed HealthSearch

Biomedical subjects

R F Cohen

Publications and source records attributed to R F Cohen.

7 recordsLinked to original sources

Interleukin-8 expression by head and neck squamous cell carcinoma.

OBJECTIVE: To test the hypothesis that interleukin-8 (IL-8) is produced by human head and neck squamous cell carcinomas (HNSCCAs) and may therefore be a possible mediator for lymphocyte recruitment and neovascularization by these tumors. METHODS: Nine fresh samples of HNSCCA were analyzed for expression of IL-8 antigen using radioimmunoassay and immunohistochemical staining techniques. Also, four short-term primary cultures of HNSCCA and two continuous HNSCCA cell lines were then analyzed for production of IL-8 expression under both baseline conditions and following stimulation with other cytokines. RESULTS: The IL-8 antigen was detected in all fresh tumor homogenates by radioimmunoassay (5.58 to 331.69 ng of IL-8 per gram of tissue), and immunohistochemical results localized staining predominantly within the tumor cells. Primary cultures of HNSCCA and continuous HNSCCA cell lines produced only low levels of IL-8 (0.04 to 4.49 ng of IL-8 per 10(6) cells) under baseline (unstimulated) conditions. Stimulation of both primary cultures and cell lines with interleukin-1 and tumor necrosis factor induced significant increases in IL-8 antigen, while other cytokines failed to induce a significant increase. CONCLUSIONS: This study demonstrates that IL-8 antigen is expressed by HNSCCA in vivo, and that cultured HNSCCA in vitro can be stimulated to express IL-8 antigen by both interleukin-1 and tumor necrosis factor. Local production of IL-8 by HNSCCA cells, and its regulation by other cytokines, may be important in both the lymphocyte recruitment and tumor neovascularization seen in HNSCCA, and may thus ultimately affect the natural history of the disease.

Carcinoma, Squamous Cell

The selective use of modified human umbilical vein as an arterial substitute in the lower extremity.

Experience with 100 MHUV grafts implanted as femoropopliteal or femorocrural bypass was reviewed to evaluate the results of this conduit obtained in a selected group of patients. Indications for use of MHUV were limited to patients in whom the autologous greater saphenous vein was either absent or unsuitable or when its use would untowardly prolong the duration of the operation in patients with a poor general condition. General medical factors contributed to the choice for MHUV grafts in 25 per cent of the patients, while lack of an adequate saphenous vein necessitated its use in 70 per cent. In 5 per cent, the patient was considered a candidate for future (re)operative coronary arterial reconstruction. Cumulative graft patency rate in femoropopliteal bypass was 75 per cent in 48 months. No significant differences could be demonstrated between categories with good, fair and poor runoff or grafts with above-knee and below-knee anastomosis. In femorocrural grafts, a two year patency rate of 56 per cent was obtained. Cumulative patency rates between anterior tibial, posterior tibial and peroneal bypass did not reveal statistical differences. Late graft failure in initially jeopardized limbs without secondary reconstruction was not associated with amputation in 47 per cent of the instances. This finding reflects the fact that collateral perfusion may increase with time. On the other hand, four patients lost a leg in spite of a functioning bypass because of distally located arterial disease not amenable for reconstruction.

Adult

Gas gangrene: a postoperative complication.

Gas gangrene, also known as clostridial myonecrosis, is a severe and acute infection usually caused by Clostridium septicum, which may contaminate a wound. On rare occasions it is a complication of elective bone surgery, although it is usually found in elderly persons after hip surgery. The onset is usually sudden and it may occur from 6 hr. to 3 days after tissue injury. Diagnosis may be difficult because of the similarity of symptoms to those of anaerobic cellulitis. Treatment consists of surgical debridement, antibiotic therapy, hyperbaric oxygen, and supportive measures. The authors review the literature, discuss the clinical aspects, and present a case history.

Adolescent

Criteria for progressive modification of neurobehavioral batteries.

Six specific issues affecting the progressive modification of neurobehavioral test batteries used in field studies of populations exposed to neurotoxicants are discussed and test review recommendations are provided addressing each issue. The issues include: (a) general test review standards, (b) comprehensive assessment, (c) tailored batteries, (d) incorporation of new tests and techniques, (e) personnel and mechanisms for review, and (f) development of a battery assessing peripheral nervous system function.

Behavior